These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7768271)

  • 1. Evidence for (+)-cicletanine sulfate as an active natriuretic metabolite of cicletanine in the rat.
    Garay RP; Rosati C; Fanous K; Allard M; Morin E; Lamiable D; Vistelle R
    Eur J Pharmacol; 1995 Feb; 274(1-3):175-80. PubMed ID: 7768271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cicletanine sulfate: inhibition of anion transport systems and natriuretic activity.
    Garay RP; Rosati C; Nazaret C; Esanu A; Tarrade T; Braquet P
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):114-9. PubMed ID: 1328892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of cell growth factors and cicletanine sulfate on the sodium-independent [Cl-/HCO3-] exchange in cultured vascular smooth muscle.
    Fanous K; Nazaret C; Senn N; Decoopman-Morin E; Allard M; Garay RP
    Am J Hypertens; 1993 Aug; 6(8):674-9. PubMed ID: 8217030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of cicletanine in the rat. Stereochemical aspects.
    Vistelle R; Lamiable D; Morin E; Trenque T; Kaltenbach M
    Drug Metab Dispos; 1995 Sep; 23(9):988-92. PubMed ID: 8565790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lack of effect of cicletanine and its sulfoconjugated metabolite on the thiazide receptor expressed in Xenopus oocytes].
    Monroy A; Plata C; Gamba G; Droy-Lefaix MT; Garay RP
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1001-4. PubMed ID: 10486654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cicletanine on renal cGMP production.
    Valdivielso JM; Morales AI; Pérez-Barriocanal F; López-Novoa JM
    Can J Physiol Pharmacol; 1998 Dec; 76(12):1151-5. PubMed ID: 10326838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the O-sulfo derivative of MK-447 as active metabolite of MK-447.
    Garay RP; Nazaret C; Cragoe EJ
    Eur J Pharmacol; 1991 Jul; 200(1):141-6. PubMed ID: 1663036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a sulfo-conjugate as active metabolite of cicletanine.
    Garay RP; Rosati C; Nazaret C; Esanu A; Berthet P; Tarrade T; Braquet P
    J Hypertens Suppl; 1991 Dec; 9(6):S342-3. PubMed ID: 1818992
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of cicletanine on kidney function. 1. Clearance and micropuncture studies in anesthetized rats.
    Greven J
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1190-6. PubMed ID: 7791090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective biotransformation of cicletanine in cultured rat and human hepatocytes.
    Menard C; Lamiable D; Vistelle R; Morin E; Ratanasavanh D
    Pharmacol Res; 2000 Jul; 42(1):87-92. PubMed ID: 10860640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cicletanine: new insights into its pharmacological actions.
    Kalinowski L; Szczepańska-Konkel M; Jankowski M; Angielski S
    Gen Pharmacol; 1999 Jul; 33(1):7-16. PubMed ID: 10428010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.
    Garay RP; Labaune JP; Mesangeau D; Nazaret C; Imbert T; Moinet G
    J Pharmacol Exp Ther; 1990 Nov; 255(2):415-22. PubMed ID: 2243333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the natriuretic and kaliuretic effects of cicletanine and hydrochlorothiazide in prehypertensive and hypertensive humans.
    Wagner F; Malice MP; Wiegert E; McGrath HE; Gildea J; Mitta S; Van Dyck K; De Lepeleire I; Johnson-Levonas AO; Sisk CM; Fernandez R; Greenwalt DM; Beals C; Carey RM; Nunes I
    J Hypertens; 2012 Apr; 30(4):819-27. PubMed ID: 22278145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salidiuretic action by genistein in the isolated, perfused rat kidney.
    Giménez I; Martinez RM; Lou M; Mayoral JA; Garay RP; Alda JO
    Hypertension; 1998 Feb; 31(2):706-11. PubMed ID: 9461244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by (-)-cicletanine of the vascular reactivity to angiotensin II and vasopressin in isolated rat vessels.
    Vargas F; Alvarez-Guerra M; Droy-Lefaix MT; Garay RP
    Am J Hypertens; 1998 May; 11(5):579-84. PubMed ID: 9633794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation by low sodium intake of glomerular response to cicletanine and atrial natriuretic factor.
    Kalinowski L; Szczepanska-Konkel M; Jankowski M; Angielski S
    Br J Pharmacol; 1997 Jun; 121(4):635-42. PubMed ID: 9208128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for medial-mass regression in the vascular wall of Dahl hypertensive rats by cicletanine treatment.
    Uehara Y; Numabe A; Kawabata Y; Nagata T; Iwai J; Matsuoka H; Yagi S; Takabatake Y; Sugimoto T
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):158-66. PubMed ID: 1719285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: beneficial effects of cicletanine.
    Szilvássy Z; Csont T; Páli T; Droy-Lefaix MT; Ferdinandy P
    J Vasc Res; 2001; 38(1):39-46. PubMed ID: 11173993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.
    Bippi H; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):215-20. PubMed ID: 3046885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.